Zhongzu Zhang

515 citations
17 papers · 391 indexed · h-index 13
Topics
MicroRNA in disease regulation (11 papers)Cancer-related molecular mechanisms research (8 papers)Sarcoma Diagnosis and Treatment (4 papers)
Partner nations
ChinaJapanUnited States

In The Last Decade

Zhongzu Zhang

17 papers receiving 388 citations

Peers

Zhongzu Zhang
Comparison fields: 5 of 56
  • Molecular Biology 276
  • Cancer Research 256
  • Pulmonary and Respiratory Medicine 42
  • Oncology 36
  • Surgery 30
Replace Hanna Kędzierska with:
Hanna Kędzierska Poland
Akiko Yashima‐Abo Japan
Shujun Yang China
Chengkui Cai China
Paula Müssnich Italy
Elisa Paviati Italy
Roberto Cirombella Italy
Wen Yuan China
Danhua Zhu China
Zhongzu Zhang relative to Hanna Kędzierska Poland Hanna Kędzierska's profile →
Citations per field
00.5×2.7×
Hanna Kędzierska · 1×
Citations per year

Countries citing papers authored by Zhongzu Zhang

Since Specialization
Citations

This map shows the geographic impact of Zhongzu Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongzu Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongzu Zhang more than expected).

Fields of papers citing papers by Zhongzu Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongzu Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongzu Zhang. The network helps show where Zhongzu Zhang may publish in the future.

Co-authorship network of co-authors of Zhongzu Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongzu Zhang. A scholar is included among the top collaborators of Zhongzu Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongzu Zhang. Zhongzu Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 5
2 17
3 4
4 31
5 19
6 18
7 28
8 32
9 7
10
A dual PI3K/AKT/mTOR signaling inhibitor miR-99a suppresses endometrial carcinoma.
39
11 18
12 25
13 23
14 9
15 37
16 37
17 42

About Zhongzu Zhang

Zhongzu Zhang is a scholar working on Cancer Research, Immunology and Allergy and Molecular Biology, having authored 17 papers that have together received 391 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (8 papers) and Sarcoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (256 citations), Molecular Biology (276 citations) and Genetics (30 citations). Zhongzu Zhang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Yunyun Li, Gaohai Shao, Qin Zhou, Zhenghua Xiao, Jiajun Chen, Xin Zhou, Jia Yu, Yanni Ma, Lei Dong and Zhimin Han. Their work appears in journals such as Nucleic Acids Research, Molecular and Cellular Biology and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026